Management of Cardiogenic Shock Attributable to Acute Myocardial Infarction in the Reperfusion Era
- 1 July 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 20 (4) , 188-198
- https://doi.org/10.1177/0885066605276802
Abstract
Cardiogenic shock is the leading cause of death among patients hospitalized with acute myocardial infarction. It is defined as tissue hypoperfusion resulting from ventricular pump failure in the presence of adequate intravascular volume. Rapid assessment and triage of patients presenting in cardiogenic shock followed by appropriate institution of supportive therapies including vasopressor and inotropic agents, mechanical ventilatory support, and intra-aortic balloon pump counterpulsation are critical for effective management of these patients. However, emergency percutaneous coronary intervention or coronary artery bypass graft surgery is required to decrease mortality rates. Novel approaches, including inhibition of nitric oxide synthase and new mechanical support devices, may further decrease mortality rates, which remain high despite reperfusion therapy.Keywords
This publication has 58 references indexed in Scilit:
- Comparison of impact of emergency percutaneous revascularization on outcome of patients ≥75 to those <75 years of age with acute myocardial infarction complicated by cardiogenic shockThe American Journal of Cardiology, 2003
- The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology, 2000
- Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology, 2000
- Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology, 2000
- Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology, 2000
- Intraaortic Balloon Pumping as Adjunctive Therapy to Rescue Coronary Angioplasty After Failed Thrombolysis in Anterior Wall Acute Myocardial InfarctionThe American Journal of Cardiology, 1995
- Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: A theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shockAmerican Heart Journal, 1993
- The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failureThe American Journal of Cardiology, 1981
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967